Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and
pharmacodynamics of multiple ascending-doses of TAK-875 in subjects with type 2 diabetes
mellitus.